As of May 29, 2025, NuVasive Inc (NUVA) reports a EV/EBITDA of 16.54.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing NuVasive Inc's EV/EBITDA to Peers
To better understand NuVasive Inc's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
| Company | EV/EBITDA |
|---|---|
| NuVasive Inc (NUVA) | 16.54 |
| Shockwave Medical Inc (SWAV) | 67.85 |
| Artivion Inc (CRY) | 22.59 |
| Natus Medical Inc (NTUS) | 21.04 |
| Integer Holdings Corp (ITGR) | 17.00 |
| Accuray Inc (ARAY) | 16.11 |
Compared to its competitors, NuVasive Inc's EV/EBITDA is among the highest compared to peers, suggesting the market values the company at a premium, possibly due to growth expectations.